- Home
- ONEW vs MNPR Comparison
ONEW vs MNPR Comparison
Compare ONEW & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- MNPR
- Stock Information
- Founded
- ONEW 2014
- MNPR 2014
- Country
- ONEW United States
- MNPR United States
- Employees
- ONEW N/A
- MNPR N/A
- Industry
- ONEW Auto & Home Supply Stores
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- ONEW Consumer Discretionary
- MNPR Health Care
- Exchange
- ONEW Nasdaq
- MNPR Nasdaq
- Market Cap
- ONEW 244.4M
- MNPR 249.5M
- IPO Year
- ONEW 2020
- MNPR 2019
- Fundamental
- Price
- ONEW $14.77
- MNPR $31.73
- Analyst Decision
- ONEW Buy
- MNPR Strong Buy
- Analyst Count
- ONEW 7
- MNPR 5
- Target Price
- ONEW $19.83
- MNPR $59.50
- AVG Volume (30 Days)
- ONEW 180.1K
- MNPR 18.2K
- Earning Date
- ONEW 07-29-2025
- MNPR 05-13-2025
- Dividend Yield
- ONEW N/A
- MNPR N/A
- EPS Growth
- ONEW N/A
- MNPR N/A
- EPS
- ONEW N/A
- MNPR N/A
- Revenue
- ONEW $1,779,631,000.00
- MNPR N/A
- Revenue This Year
- ONEW $1.77
- MNPR N/A
- Revenue Next Year
- ONEW $4.88
- MNPR N/A
- P/E Ratio
- ONEW N/A
- MNPR N/A
- Revenue Growth
- ONEW N/A
- MNPR N/A
- 52 Week Low
- ONEW $11.58
- MNPR $1.72
- 52 Week High
- ONEW $31.36
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- ONEW 52.57
- MNPR 37.28
- Support Level
- ONEW $13.41
- MNPR $34.02
- Resistance Level
- ONEW $15.00
- MNPR $36.82
- Average True Range (ATR)
- ONEW 0.72
- MNPR 3.54
- MACD
- ONEW 0.07
- MNPR -0.71
- Stochastic Oscillator
- ONEW 55.60
- MNPR 27.91
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.